Viridian Therapeutic (VRDN) PT Lowered to $37 at H.C. Wainwright
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts VRDN Hot Sheet
Price: $22.37 -1.97%
Rating Summary:
16 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Rating Summary:
16 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Join SI Premium – FREE
H.C. Wainwright analyst Douglas Tsao lowered the price target on Viridian Therapeutic (NASDAQ: VRDN) to $37.00 (from $40.00) while maintaining a Buy rating.
You May Also Be Interested In
- Viridian Intersects 15m of 1.1% CuEq in 1.5km Step-Out Drilling at Kraken Main
- RingCentral (RNG) PT Raised to $105 at FBN Securities
- Deckers Outdoor (DECK) PT Lowered to $100 at Williams Trading
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
